- Home
- ISRG vs PFE Comparison
ISRG vs PFE Comparison
Compare ISRG & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISRG | PFE |
|---|---|---|
| Founded | 1995 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.8B | 147.6B |
| IPO Year | 1998 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ISRG | PFE |
|---|---|---|
| Price | $347.30 | $25.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 14 |
| Target Price | ★ $591.32 | $29.29 |
| AVG Volume (30 Days) | 2.4M | ★ 37.8M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.55% |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 2.28 | 0.47 |
| Revenue | $10,064,700,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $16.64 | N/A |
| Revenue Next Year | $13.91 | N/A |
| P/E Ratio | $176.84 | ★ $53.40 |
| Revenue Growth | ★ 20.51 | N/A |
| 52 Week Low | $378.50 | $23.11 |
| 52 Week High | $603.88 | $28.75 |
Technical Indicators
Market Signals| Indicator | ISRG | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 31.02 | 54.63 |
| Support Level | N/A | $25.06 |
| Resistance Level | $441.56 | $26.42 |
| Average True Range (ATR) | 14.01 | 0.46 |
| MACD | -4.10 | 0.17 |
| Stochastic Oscillator | 0.92 | 73.65 |
Price Performance
Historical ComparisonAbout ISRG Intuitive Surgical Inc.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.